Long-term Survival Benefit of Eculizumab Treatment in Patients With Paroxysmal Nocturnal Haemoglobinuria: Data From the International PNH Registry

被引:0
|
作者
Griffin, Morag [1 ]
Terriou, Louis [2 ]
Patriquin, Christopher J. [3 ]
Lee, Jong Wook [4 ]
Gustovic, Philippe [5 ]
Patel, Ami S. [6 ]
Szer, Jeff [7 ,8 ]
机构
[1] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England
[2] CHU Lille, Serv Med Interne & Immunol Clin, Lille, France
[3] Univ Toronto, Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea
[5] Alex, AstraZeneca Rare Dis, Zurich, Switzerland
[6] Alex, AstraZeneca Rare Dis, Boston, MA USA
[7] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH22-OR06
引用
收藏
页码:8 / 9
页数:2
相关论文
共 50 条
  • [31] Benefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia
    Kulagin, Aleksandr
    Klimova, Olesya
    Rudakova, Tatiana
    Golubovskaya, Irina
    Ivanova, Maria
    Smirnova, Anna
    Lapina, Alexandra
    Bykova, Tatiana
    Babenko, Elena
    Popova, Marina
    Dobronravov, Vladimir
    Afanasyev, Boris
    BLOOD, 2018, 132
  • [32] Efficacy of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and High Disease Activity with or without History of Aplastic Anemia in the International PNH Registry
    Lee, Jong-Wook
    De latour, Regis Peffault
    Brodsky, Robert A.
    Jang, Jun Ho
    Hill, Anita
    Roeth, Alexander
    Schrezenmeier, Hubert
    Wilson, Amanda
    Marantz, Jing L.
    Maciejewski, Jaroslaw P.
    BLOOD, 2017, 130
  • [33] Incomplete Complement Inhibition In Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH) On Eculizumab-5 Year Experience From The National PNH Service Leeds
    Jones, Rachael
    Muus, Petra
    Munir, Talha
    Pike, Alexandra
    Arnold, Louise
    Gachev, Jeanifer
    Forrest, Briony
    Hillmen, Peter
    Griffin, Morag
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 201 - 202
  • [34] Clinically Important Difference for the FACIT-Fatigue Scale in Paroxysmal Nocturnal Haemoglobinuria: A Derivation From International PNH Registry Patient Data
    Cella, David
    Johansson, Peter
    Ueda, Yasutaka
    Tomazos, Ioannis
    Gustovic, Philippe
    Wang, Alice
    Patel, Ami S.
    Schrezenmeier, Hubert
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 142 - 142
  • [35] SURGICAL MANAGEMENT OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) - DATA FROM THE SPANISH PNH REGISTRY
    De La Iglesia, S.
    Notario McDonell, C.
    Gaya Valls, A.
    Cedena Romero, M. T.
    Gomez Roncero, M. I.
    Arrizabalaga Amunchastegui, B.
    Monteserin Monteserin, C.
    Lavilla Rubira, E.
    Villegas Martinez, A. M.
    HAEMATOLOGICA, 2017, 102 : 403 - 404
  • [36] Data From The Russian Cohort Of The International Disease Registry For Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Lisukov, Igor
    Kulagin, Alexander
    Maschan, Alexey
    Shilova, Elena
    Abdulkadyrov, Kudrat
    Zaritskiy, Andrey
    Ivanova, Valentina
    Bogdanova, Yulia
    Volkova, Svetlana
    Gavrilenko, Andrey
    Kaporskaya, Tatyana S.
    Meresiy, Sergey
    Schneider, Tatyana
    Yakupova, Svetlana
    Anchukova, Ludmila
    Bakirov, Bulat
    Kosacheva, Natalia
    Krinitsina, Tatiana
    Ustyantseva, Viktoria
    Shatokhin, Yuriy
    BLOOD, 2013, 122 (21)
  • [37] Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies
    Roeth, Alexander
    Fu, Rong
    He, Guangsheng
    Alzahrani, Hazzaa
    Chou, Sheng-Chieh
    Hicheri, Yosr
    Kazmierczak, Maciej
    Recova, Viviane Lacorte
    Uchiyama, Michihiro
    Vladareanu, Ana-Maria
    Beveridge, Leigh
    Buatois, Simon
    Buri, Muriel
    Compagno, Nicolo
    Shi, Dayu
    Balachandran, Nadiesh
    Sreckovic, Sasha
    Scheinberg, Phillip
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (02) : 373 - 382
  • [38] The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis
    Muus, P.
    Duehrsen, U.
    Elebute, M.
    Browne, P.
    Urbano-Ispizua, A.
    Coutre, S.
    Van Den Neste, E.
    De Paz, R.
    Konkle, B.
    Moskovits, T.
    Nakamura, R.
    Zanella, A.
    Hillmen, P.
    Rother, R. P.
    Soci, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 137 - 138
  • [39] Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Kulagin, Alexander D.
    Ptushkin, Vadim V.
    Lukina, Elena A.
    Davydkin, Igor L.
    Korobkin, Alexander V.
    Konstantinova, Tatiana S.
    Komartseva, Elena Yu.
    Minaeva, Natalia V.
    Mitina, Tatiana A.
    Klimova, Olesya U.
    Arshanskaya, Evgeniya G.
    Latyshev, Vitalii D.
    Markova, Oksana A.
    Zuev, Eugene V.
    ACTA HAEMATOLOGICA, 2024,
  • [40] Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial
    Roeth, Alexander
    Ichikawa, Satoshi
    Ito, Yoshikazu
    Kim, Jin Seok
    Nagy, Zsolt
    Obara, Naoshi
    Panse, Jens
    Schrezenmeier, Hubert
    Sica, Simona
    Soret, Juliette
    Usuki, Kensuke
    Yoon, Sung-Soo
    Balachandran, Nadiesh
    Buri, Muriel
    Lundberg, Pontus
    Patel, Himika
    Shinomiya, Kenji
    Sostelly, Alexandre
    Nishimura, Jun-ichi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (02) : 300 - 310